Does the pharmaceutical industry prevent the media from discussing alternatives to the patent system for financing drug research? That would seem to be the case, since an NYT article on the failure of the industry to pursue the development of new antibiotics never once mentioned alternatives to relying on the current patent system.

It does not plan to offer government subsidies in addition to patent monopolies or proposals to make these monopolies even longer, but never considers the possibility that the research would simply be financed directly through public funds with all the findings placed in the public domain. Is there just a mental blockage here or is something else going on? 

 survey banner

subscribe today!

Site Maintenance

"The CEPR website currently takes longer to load than usual. We hope to have this and other issues addressed shortly. While this much needed site maintenance is taking place, our content is still available so please continue to slooowwwly surf the pages of our site. Thank you for your patience."